[1]
许可, 蒋春梅, 邓小昭, 丁伟良, 谈永飞, 张云, 2006: Study On the Variation of E2 of 1b Hepatitis C Virus in the South of Jiangsu Province, Virologica Sinica, 21, 333-338.
[2]
潘文胜, 王海涛, 汪涛, 郭华章, 骆抗先, 1998: Genetic variation characteristics of hepatitis C virus hypervariable region, Virologica Sinica, 13, 221-.
[3]
程险峰, 戴星, 孟继鸿, 张红梅, 周镇先, 丁福, 梁久红, 耿全林, 2005: Genotype Identification and Variation Analysis of Hepatitis E Virus Isolated in Nanjing, China, Virologica Sinica, 20, 468-471.
[4]
Yin-ping LU, Bao-ju WANG, Ji-hua DONG, Zhao LIU, Shi-he GUAN, Meng-ji LU, Dong-liang YANG, 2007: Construction and Characterization of a Hepatitis B Virus Replicon, Virologica Sinica, 22, 8-13.
[5]
Ju-sheng LIN, Lin-lin GAO, 2008: Advances in Research on Hepatitis B Virus DNA Integration, Virologica Sinica, 23, 93-99. doi: 10.1007/s12250-008-2939-6
[6]
Jianhao Cao, Shuhong Luo, Yuanyan Xiong, 2019: The Variability of Amino Acid Sequences in Hepatitis B Virus, Virologica Sinica, 34, 42-49. doi: 10.1007/s12250-018-0070-x
[7]
Yang XU, Chun-wei SHE, Xiao-yong ZHANG, Rong-juan PEI, Meng-ji LU, 2008: Interference of Hepatitis B Virus with Cellular Signaling^*, Virologica Sinica, 23, 100-106. doi: 10.1007/s12250-008-2940-0
[8]
Felicia Tucci, Ralf Küppers, 2014: Role of hepatitis C virus in B cell lymphoproliferations, Virologica Sinica, 29, 3-6. doi: 10.1007/s12250-014-3414-1
[9]
熊开钧, 王心禾, 黄华芳, 姚梦林, 代家珠, 金慰鄂, 范红梅, 曾全兰, 张雪珍, 1987: THE OBSERVATION OF A TREATED RESULT WITH ACYCLOVIR IN HEPATITIS B VIRUS, Virologica Sinica, 2, 78-.
[10]
吴婷, 黄海, 1998: The Inhibitory Effects of Enduracidin on Hepatitis B Virus in vitro, Virologica Sinica, 13, 45-.
[11]
郭亚兵, 侯金林, 戴炜, 骆抗先, P.Karayiannis, 1999: Sequencing of the W hole Gene of Hepatitis B Virus, Virologica Sinica, 14, 205-209.
[12]
范涛, 傅希贤, 张国庆, 张乃临, 1994: The Inhibitory Effects of Quinolones on Hepatitis B Virus in Vitro, Virologica Sinica, 9, 113-118.
[13]
Dong XI, Zhi-Mo WANG, Sui GAO, Chuan-Long ZHU, Jian-Wen GUO, Xiao-Ping LUO, Qin Ning, 2007: Construction of shRNA of Fulminant Hepatitis Related Gene mfgl2 and Investigation of Its Biological Effects in vitro*, Virologica Sinica, 22, 366-373.
[14]
Chunchen Wu, Hui Shi, Yun YunWang, Mengji Lu, Yang Xu, Xinwen Chen, 2012: A Case of Hepatitis B Reactivation due to the Hepatitis B Virus Escape Mutant in a Patient undergoing Chemotherapy ^*, Virologica Sinica, 27, 369-372. doi: 10.1007/s12250-012-3284-3
[15]
曾令兰, 熊开钧, 黄华芳, 何生松, 罗端德, 王心禾, 代家珠, 刘红艳, 1991: Study on Intercellular Virus Replication in the Patients Continually Infected by Hepatitis B Virus, Virologica Sinica, 6, 43-.
[16]
Xueyu Wang, Zhiqiang Wei, Yongfang Jiang, Zhongji Meng, Mengji Lu, 2021: mTOR Signaling: The Interface Linking Cellular Metabolism and Hepatitis B Virus Replication, Virologica Sinica, 36, 1303-1314. doi: 10.1007/s12250-021-00450-3
[17]
Hui FENG, Kang-hong HU, 2009: Structural Characteristics and Molecular Mechanism of Hepatitis B Virus Reverse Transcriptase, Virologica Sinica, 24, 509-517. doi: 10.1007/s12250-009-3076-6
[18]
Yongjun Tian, Jing-hsiung James Ou, 2015: Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma, Virologica Sinica, 30, 85-91. doi: 10.1007/s12250-015-3582-7
[19]
Pinghu Zhang, Shuo Zhai, Jinhong Chang, Ju-Tao Guo, 2018: In Vitro Anti-hepatitis B Virus Activity of 2', 3'-Dideoxyguanosine, Virologica Sinica, 33, 538-544. doi: 10.1007/s12250-018-0065-7
[20]
Wanyu Deng, Mengji Lu, 2016: The role of microRNAs in hepatocyte metabolism and hepatitis B virus replication, Virologica Sinica, 31, 472-479. doi: 10.1007/s12250-016-3924-0